Literature DB >> 11096216

Combined therapy of corticosteroid and azathioprine in hypertrophic cranial pachymeningitis.

I S Choi1, S C Park, Y K Jung, S S Lee.   

Abstract

Hypertrophic cranial pachymeningitis (HCP) is a rare inflammatory disease of unknown origin in which recurrence is frequently observed in spite of the initial response to steroid therapy. Three patients, 1 man and 2 women, aged 63, 66, and 67 years, with severe intractable headache were evaluated by brain MRI. All patients were initially given prednisolone (60 mg/day, oral) or dexamethasone (20 mg/day, i.v.), and followed by long-term (at least 1 year) azathioprine therapy. All patients were evaluated by follow-up laboratory tests and brain MRI study, and completed the 2-year follow-up period. Symptoms including headache were initially improved with corticosteroid therapy, but patients became steroid-dependent. Azathioprine administration in these steroid-dependent patients permitted the complete cessation of corticosteroid and led to the clinical and radiological recovery. In conclusion, initial high-dose corticosteroid administration followed by long-term azathioprine therapy may be the ideal treatment of HCP at present. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096216     DOI: 10.1159/000008235

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  6 in total

1.  Wave-like appearance of diffuse pachymeningeal enhancement associated with intracranial hypotension.

Authors:  M Tosaka; N Sato; H Fujimaki; A Takahashi; N Saito
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

Review 2.  [Hypertrophic cranial pachymeningitis as a rare cause of headache].

Authors:  J Kuhn; A Harzheim; S Riku; W Müller; H Bewermeyer
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

Review 3.  Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.

Authors:  Armando De Virgilio; Marco de Vincentiis; Maurizio Inghilleri; Giovanni Fabrini; Michela Conte; Andrea Gallo; Maria Ida Rizzo; Antonio Greco
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  A case of hypertrophic cranial pachymeningitis presenting with scleritis in a patient with undifferentiated connective tissue disease.

Authors:  Ji-Hyeon Kim; Young-Bin Joo; Jeana Kim; Jun-Ki Min
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

5.  Idiopathic hypertrophic cranial pachymeningitis: Three biopsy-proven cases including one case with abdominal pseudotumor and review of the literature.

Authors:  K M Hassan; Prabal Deb; H S Bhatoe
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

6.  Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis.

Authors:  Yoonhyuk Jang; Soon Tae Lee; Keun Hwa Jung; Kon Chu; Sang Kun Lee
Journal:  J Clin Neurol       Date:  2017-03-06       Impact factor: 3.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.